Table of Contents
✨ Onyx Summary
Recursion announced its participation in the Guggenheim 2nd Annual Healthcare Innovation Conference on November 11 and the Jefferies Global Healthcare Conference in London on November 18, 2025.
Live webcasts of both events will be available on the company’s investor relations website.
Salt Lake City, Nov. 04, 2025 – Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
- Guggenheim 2nd Annual Healthcare Innovation Conference —Tuesday, November 11, 2025
- Jefferies Global Healthcare Conference London —Tuesday, November 18, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered inSalt Lake City, where it is a founding member of BioHive, the Utahlife sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxfordarea. Learn more at www.Recursion.com, or connect on X and LinkedIn.
Investor Contact
investor@recursion.com
Media Contact
media@recursion.com
